Premium
BONES AND STONES
Author(s) -
Smith Daron,
Laing Chris
Publication year - 2011
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2011.10182.x
Subject(s) - university hospital , medicine , general hospital , library science , general surgery , computer science
© 2 0 11 T H E A U T H O R S 1 9 0 8 B J U I N T E R N A T I O N A L © 2 0 11 B J U I N T E R N A T I O N A L 19 Peris P, Martínez-Ferrer A, Monegal A et al. Aetiology and clinical characteristics of maleosteoporosis. Have they changed in the last few years? Clin Exp Rheumatol 2008; 26: 582–8 20 Schwaderer AL, Cronin R, Mahan JD, Bates CM. Low bone density in children with hypercalciuria and/or nephrolithiasis. Pediatr Nephrol 2008; 23: 2209–14 21 García-Nieto V, Ferrández C, Monge M, de Sequera M, Rodrigo MD. Bone mineral density in pediatric patients with idiopathic hypercalciuria. Pediatr Nephrol 1997; 11: 578–83 22 Tsuji H, Umekawa T, Kurita T et al. Analysis of bone mineral density in urolithiasis patients. Int J Urol 2005; 12: 335–9 23 Yasui T, Itoh Y, Okada A et al. Alendronate reduces the excretion of risk factors for calcium phosphate stone formation in postmenopausal women with osteoporosis. Urol Int 2009; 83: 226– 9 24 Freundlich M, Alon US. Bisphosphonates in children with hypercalciuria and reduced bone mineral density. Pediatr Nephrol 2008; 23: 2215– 20